MOXETUMOMAB PASUDOTOX-TDFK | B761104 | INNATE PHARMA
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Sep. 13, 2030 | Active | Computed |
| 7-Year Orphan | Sep. 13, 2025 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12377164(composition) · relevance 50/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
28 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.